164 related articles for article (PubMed ID: 25196202)
21. Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study.
Villamañán E; Sobrino C; Bilbao C; Fernández J; Herrero A; Calle M; Alvaro D; Segura M; Picazo G; Rodríguez JM; Baldominos G; Ramirez MT; Larrubia Y; Llorente J; Martinez A; Alvarez-Sala R
Eur J Hosp Pharm; 2021 Nov; 28(Suppl 2):e23-e28. PubMed ID: 32332071
[TBL] [Abstract][Full Text] [Related]
22. Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol.
Ruiz-Antorán B; Agustí Escasany A; Vallano Ferraz A; Danés Carreras I; Riba N; Mateu Escudero S; Costa J; Sánchez Santiago MB; Laredo L; Durán Quintana JA; Castillo JR; Abad-Santos F; Payares Herrera C; Sádaba Díaz de Rada B; Gómez Ontañón E
Eur J Clin Pharmacol; 2010 Jun; 66(6):633-41. PubMed ID: 20204337
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014.
Tukayo BLA; Sunderland B; Parsons R; Czarniak P
PLoS One; 2020; 15(1):e0227687. PubMed ID: 31935254
[TBL] [Abstract][Full Text] [Related]
24. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
de Kuijper GM; Hoekstra PJ
J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
[TBL] [Abstract][Full Text] [Related]
25. Off-label use of medicines in paediatric inpatients at an Australian teaching hospital.
Ballard CD; Peterson GM; Thompson AJ; Beggs SA
J Paediatr Child Health; 2013 Jan; 49(1):38-42. PubMed ID: 23279160
[TBL] [Abstract][Full Text] [Related]
26. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
27. Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey.
Rossi-Semerano L; Fautrel B; Wendling D; Hachulla E; Galeotti C; Semerano L; Touitou I; Koné-Paut I;
Orphanet J Rare Dis; 2015 Feb; 10():19. PubMed ID: 25758134
[TBL] [Abstract][Full Text] [Related]
28. Unlicensed and off-label use of drugs in pediatric surgical units at tertiary care hospitals of Pakistan.
Aamir M; Khan JA; Shakeel F; Asim SM
Int J Clin Pharm; 2017 Aug; 39(4):860-866. PubMed ID: 28597174
[TBL] [Abstract][Full Text] [Related]
29. Retrospective Analysis of Emerging Drugs Use in a Quebec Women's and Children's University Hospital and Perspectives for Safe and Optimal Drug Use.
Corny J; Pelletier E; Lebel D; Bussières JF
J Popul Ther Clin Pharmacol; 2017 Mar; 24(1):e56-e64. PubMed ID: 28282104
[TBL] [Abstract][Full Text] [Related]
30. Prospective data collection of off-label use of rituximab in Australian public hospitals.
O'Connor K; Liddle C
Intern Med J; 2013 Aug; 43(8):863-70. PubMed ID: 23735074
[TBL] [Abstract][Full Text] [Related]
31. Off-label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study.
Mazhar F; Akram S; Haider N; Hadi MA; Sultana J
Int J Clin Pharm; 2018 Jun; 40(3):700-703. PubMed ID: 29721741
[TBL] [Abstract][Full Text] [Related]
32. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
33. [Drug prescriptions study in the outpatient setting: assessment of off-label uses in children].
Blanco-Reina E; Vega-Jiménez MA; Ocaña-Riola R; Márquez-Romero EI; Bellido-Estévez I
Aten Primaria; 2015; 47(6):344-50. PubMed ID: 25443768
[TBL] [Abstract][Full Text] [Related]
34. Off-label prescribing of antiepileptic drugs in pharmacoresistant epilepsy: a cross-sectional drug utilization study of tertiary care centers in Italy.
Franco V; Canevini MP; Capovilla G; De Sarro G; Galimberti CA; Gatti G; Guerrini R; La Neve A; Rosati E; Specchio LM; Striano S; Tinuper P; Perucca E
CNS Drugs; 2014 Oct; 28(10):939-49. PubMed ID: 25056568
[TBL] [Abstract][Full Text] [Related]
35. Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.
Simsek M; Lissenberg-Witte BI; van Riswijk MLM; Verschuren S; Hoentjen F; Oldenburg B; Ponsioen CY; van der Woude CJ; van der Meulen AE; Pierik M; Dijkstra G; de Boer NKH;
Aliment Pharmacol Ther; 2019 May; 49(10):1293-1300. PubMed ID: 30908719
[TBL] [Abstract][Full Text] [Related]
36. Off-label and unlicensed drug use in a Spanish Neonatal Intensive Care Unit.
Arocas Casañ V; Cabezuelo Escribano B; Garrido-Corro B; De la Cruz Murie P; Blázquez Álvarez MJ; De la Rubia Nieto MªA
Farm Hosp; 2017 May; 41(3):371-381. PubMed ID: 28478751
[TBL] [Abstract][Full Text] [Related]
37. Off-label psychotropic prescribing for young persons in medium security.
Haw C; Stubbs J
J Psychopharmacol; 2010 Oct; 24(10):1491-8. PubMed ID: 19423609
[TBL] [Abstract][Full Text] [Related]
38. The extent to which off-patent registered prescription medicines are used for off-label indications in Australia: A scoping review.
Howe K; Bourke S; Sansom L
PLoS One; 2021; 16(12):e0261022. PubMed ID: 34860857
[TBL] [Abstract][Full Text] [Related]
39. Use of off-label and unlicensed medicines in neonatal intensive care.
Costa HTML; Costa TX; Martins RR; Oliveira AG
PLoS One; 2018; 13(9):e0204427. PubMed ID: 30252920
[TBL] [Abstract][Full Text] [Related]
40. Safety and Efficacy of Off-label and Unlicensed Medicines in Children.
Lee JH; Byon HJ; Choi S; Jang YE; Kim EH; Kim JT; Kim HS
J Korean Med Sci; 2018 Sep; 33(37):e227. PubMed ID: 30190655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
